PANCYTOVIR
Live / Allowed — Fifth extension granted (statement of use) (as of 14 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Jul 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97512013
- Mark type
- Word mark
- Filed
- 20 Jul 2022
- Published for opposition
- 17 Oct 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the nature of antivirals; pharmaceutical preparations in the nature of antivirals for both the prevention and treatment of respiratory viruses and their mutations or variants
Owner
- TrippBio, Inc., Jacksonville, FL, US
- TrippBio, Inc., Jacksonville, FL, US
Prosecution history
- 14 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2026 — SOU EXTENSION 5 GRANTED
- 12 Jun 2026 — SOU EXTENSION 5 FILED
- 14 Sept 2026 — SOU EXTENSION 4 GRANTED
- 12 Dec 2025 — SOU EXTENSION 4 FILED
- 11 Sept 2026 — NOTICE OF REVIVAL - E-MAILED
- 11 Sept 2026 — PETITION GRANTED - EXTENSION REQUEST FILED
- 11 Sept 2026 — PETITION TO DIRECTOR GRANTED
- 10 Sept 2026 — TEAS RESPONSE TO PETITION INQUIRY LETTER
- 10 Sept 2026 — PETITION INQUIRY LETTER ISSUED
- 04 Sept 2026 — PETITION INQUIRY LETTER ISSUED
- 04 Sept 2026 — ASSIGNED TO PETITION STAFF
- 09 Apr 2026 — TEAS PETITION TO DIRECTOR RECEIVED
- 12 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED